首站-论文投稿智能助手
典型文献
Animal models of pulmonary hypertension due to left heart disease
文献摘要:
Pulmonary hypertension due to left heart disease (PH- LHD) is regarded as the most prevalent form of pulmonary hypertension (PH). Indeed, PH is an independent risk factor and predicts adverse prognosis for patients with left heart disease (LHD). Clinically, there are no drugs or treatments that directly address PH- LHD, and treat-ment of LHD alone will not also ameliorate PH. To target the underlying physiopatho-logical alterations of PH- LHD and to develop novel therapeutic approaches for this population, animal models that simulate the pathophysiology of PH- LHD are required. There are several available models for PH- LHD that have been successfully employed in rodents or large animals by artificially provoking an elevated pressure load on the left heart, which by transduction elicits an escalated pressure in pulmonary artery. In addition, metabolic derangement combined with aortic banding or vascular en-dothelial growth factor receptor antagonist is also currently applied to reproduce the phenotype of PH- LHD. As of today, none of the animal models exactly recapitulates the condition of patients with PH- LHD. Nevertheless, the selection of an appropriate animal model is essential in basic and translational studies of PH- LHD. Therefore, this review will summarize the characteristics of each PH- LHD animal model and discuss the advantages and limitations of the different models.
文献关键词:
作者姓名:
Shao-Fei Liu;Yi Yan
作者机构:
Charité—Universit?tsmedizin Berlin, Corporate Member of Freie Universit?t Berlin,Humboldt-Universit?t zu Berlin, and Berlin Institute of Health,Berlin, Germany;DZHK(German Centre for Cardiovascular Research),Partner Site Berlin,Berlin, Germany;Institute for Cardiovascular Prevention (IPEK),Ludwig-Maximilians-University Munich,Munich,Germany;DZHK(German Centre for Cardiovascular Research),Partner Site Munich Heart Alliance,Munich,Germany
引用格式:
[1]Shao-Fei Liu;Yi Yan-.Animal models of pulmonary hypertension due to left heart disease)[J].动物模型与实验医学(英文),2022(03):197-206
A类:
physiopatho,provoking,derangement,recapitulates
B类:
Animal,models,pulmonary,hypertension,due,left,heart,disease,Pulmonary,PH,LHD,regarded,most,prevalent,form,Indeed,independent,risk,predicts,adverse,prognosis,patients,Clinically,there,are,drugs,treatments,that,directly,address,alone,will,also,ameliorate,To,target,underlying,logical,alterations,develop,novel,therapeutic,approaches,this,population,simulate,pathophysiology,required,several,available,have,been,successfully,employed,rodents,large,animals,by,artificially,elevated,pressure,load,which,transduction,elicits,escalated,artery,addition,metabolic,combined,aortic,banding,vascular,dothelial,growth,receptor,antagonist,currently,applied,reproduce,phenotype,today,none,exactly,condition,Nevertheless,selection,appropriate,essential,basic,translational,studies,Therefore,review,summarize,characteristics,each,discuss,advantages,limitations,different
AB值:
0.515675
相似文献
Prevalence, risk factors, and survival associated with pulmonary hypertension and heart failure among patients with underlying coronary artery disease: a national prospective, multicenter registry study in China
Huang Li;Pang Lingpin;Gu Qing;Yang Tao;Li Wen;Quan Ruilin;Su Weiqing;Wu Weifeng;Tang Fangming;Zhu Xiulong;Shen Jieyan;Sun Jingzhi;Shan Guangliang;Xiong Changming;Huang Shian;He Jianguo-Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, China;Cardiovascular Medicine Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 510180, China;Center of Pulmonary Vascular Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100007, China;Department of Cardiology, Lianjiang People’s Hospital, Lianjiang, Guangdong 524499, China;Department of Cardiology, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, China;Department of Cardiology, Nongken Central Hospital of Guangdong Province, Zhanjiang, Guangdong 529632, China;Department of Cardiology, People’s Hospital of Gaozhou, Gaozhou, Guangdong 525232, China;Department of Cardiology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China;Department of Cardiology, Affiliated Hospital of Jining Medical University, Jining, Shandong 272007, China;Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing 100006, China
Chalcone derivatives ameliorate lipopolysaccharide-induced acute lung injury and inflammation by targeting MD2
Ya-li Zhang;Wen-xin Zhang;Jue-qian Yan;Ye-lin Tang;Wen-jing Jia;Zheng-wei Xu;Ming-jiang Xu;Nipon Chattipakorn;Yi Wang;Jian-peng Feng;Zhi-guo Liu;Guang Liang-Chemical Biology Research Center,School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou 325035,China;Key Laboratory of Molecular Pharmacology and Drug Evaluation(Yantai University),Ministry of Education,Yantai University,Yantai 264005,China;School of Pharmaceutical Sciences,Hangzhou Medical College,Hangzhou 311399,China;Zhuji Biomedicine Institute,School of Pharmaceutical Sciences,Wenzhou Medical University,Zhuji 311800,China;Cardiac Electrophysiology Research and Training Center,Faculty of Medicine,Chiang Mai University,Chiang Mai 50200,Thailand;Wenzhou Institute,University of Chinese Academy of Sciences,Wenzhou 325001,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。